Last reviewed · How we verify
Allogeneic cord blood platelet gel-CBPG
Allogeneic cord blood platelet gel-CBPG is a Biological wound healing product Biologic drug developed by Centro Nazionale Sangue. It is currently in Phase 3 development for Chronic wounds and ulcers, Acute and surgical wounds.
Allogeneic cord blood platelet gel provides a biological scaffold enriched with growth factors and cytokines from cord blood-derived platelets to promote wound healing and tissue regeneration.
Allogeneic cord blood platelet gel provides a biological scaffold enriched with growth factors and cytokines from cord blood-derived platelets to promote wound healing and tissue regeneration. Used for Chronic wounds and ulcers, Acute and surgical wounds.
At a glance
| Generic name | Allogeneic cord blood platelet gel-CBPG |
|---|---|
| Sponsor | Centro Nazionale Sangue |
| Drug class | Biological wound healing product |
| Modality | Biologic |
| Therapeutic area | Wound Care / Regenerative Medicine |
| Phase | Phase 3 |
Mechanism of action
This product combines allogeneic (donor-derived) cord blood platelets in a gel matrix that releases bioactive molecules including growth factors, cytokines, and chemokines. These factors stimulate angiogenesis, cell proliferation, and extracellular matrix deposition to accelerate wound healing and tissue repair. The gel formulation allows localized delivery and sustained release of these regenerative signals at the wound site.
Approved indications
- Chronic wounds and ulcers
- Acute and surgical wounds
Common side effects
- Infection at application site
- Allergic reaction
- Delayed wound healing
Key clinical trials
- Clinical Efficacy of Platelet Gel From Cord Blood for the Treatment of Diabetic Foot Ulcers (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Allogeneic cord blood platelet gel-CBPG CI brief — competitive landscape report
- Allogeneic cord blood platelet gel-CBPG updates RSS · CI watch RSS
- Centro Nazionale Sangue portfolio CI
Frequently asked questions about Allogeneic cord blood platelet gel-CBPG
What is Allogeneic cord blood platelet gel-CBPG?
How does Allogeneic cord blood platelet gel-CBPG work?
What is Allogeneic cord blood platelet gel-CBPG used for?
Who makes Allogeneic cord blood platelet gel-CBPG?
What drug class is Allogeneic cord blood platelet gel-CBPG in?
What development phase is Allogeneic cord blood platelet gel-CBPG in?
What are the side effects of Allogeneic cord blood platelet gel-CBPG?
Related
- Drug class: All Biological wound healing product drugs
- Manufacturer: Centro Nazionale Sangue — full pipeline
- Therapeutic area: All drugs in Wound Care / Regenerative Medicine
- Indication: Drugs for Chronic wounds and ulcers
- Indication: Drugs for Acute and surgical wounds
- Compare: Allogeneic cord blood platelet gel-CBPG vs similar drugs
- Pricing: Allogeneic cord blood platelet gel-CBPG cost, discount & access